Last reviewed · How we verify
NCT07089979: GCR
Effectiveness of Glunovo Real-Time Continuous Glucose Monitoring in Adults With Type 2 Diabetes
NA trial testing Glunovo CGM device in Glucose Monitoring, Continuous in 260 participants. Completed in 15 July 2024.
1 July 2024
Quick facts
| Lead sponsor | University of Milan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 260 |
| Start date | 1 January 2024 |
| Primary completion | 1 July 2024 |
| Estimated completion | 15 July 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Glunovo CGM device
- BG-meter
Conditions studied
- Glucose Monitoring, Continuous — all drugs for Glucose Monitoring, Continuous →
Sponsor
University of Milan
Who can join
Adults 18 to 100, any sex, with Glucose Monitoring, Continuous. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to evaluate the effectiveness of the novel Real-Time Continuous Glucose Monitoring (RT-CGM) system "Glunovo" in improving glycemic control and patient-reported outcomes in individuals with poorly controlled Type 2 Diabetes (T2D).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A Randomized Study of the <i>Glunovo</i> Real-time CGM Effectiveness in Individuals With Poorly Controlled Type 2 Diabetes.
Lazzaroni E, Cimino V, Gandolfi A, Tinari C, et al · · 2026 · PMID 41551204 · DOI 10.1210/jendso/bvaf165
Verify or expand the search:
- PubMed search for NCT07089979
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Glucose Monitoring, Continuous
Currently open trials in the same condition.
- NCT07402382 — Effects of Amylopectin Chromium Blend on Whole-Body Protein Kinetics and Glucose in Peri/Post-Menopausal Women · NA · recruiting
Other University of Milan trials
Trials by the same sponsor.
- NCT07476417 — Oral Health, Dento-facial Condition and OHRQoL in Subjects With Mowat-Wilson Syndrome: an Epidemiologic Study. · not yet recruiting
- NCT07259902 — FMRI Study on DC/TMD Patients · NA · not yet recruiting
- NCT07273123 — The Effect of Prolonged Sugar-Free Chewing Gum Mastication on Self-Reported Fatigue Levels and Changes of Static and Dyn · recruiting
- NCT07262437 — Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles · NA · active not recruiting
- NCT07312305 — Small Airways Disease Functional Assessment in Idiopathic Pulmonary Fibrosis (SWIFT-IPF) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07089979 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Milan
- Last refreshed: 29 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07089979.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing